FDA Grants Breakthrough Device Designation for CRISPR Blood Test for Tuberculosis
IntelliGenome's CRISPR-TB Blood Test, designed to detect Mycobacterium tuberculosis cfDNA, received FDA Breakthrough Device Designation.
Tag: TB
All
Latest
All
Latest
Automated Preanalytical Processing of Whole Blood Samples
Tecan and Qiagen collaborate to optimize sample preparation for latent tuberculosis testing.
All
LatestWellcome Sanger Institute Sequences Reference Genomes of 3,000 Dangerous Bacteria
Dysentery, gonorrhea, and plague are among the collection of bacterial genomes now publicly available through a collaboration with Pacific Biosciences.
The Value of Diagnostics
Experts in the field discuss their views on the value of diagnostics, and how changing views are affecting the adoption and use of such tests.
Read MoreUSAID, Cepheid Join Forces to Battle Multidrug-Resistant Tuberculosis
Cepheid has signed a memorandum of understanding representing its intention to work with USAID to support the White House’s national action plan for combating MDR-TB.
Read More
Chinese Study Finds Tuberculin Skin Test Overestimates Latent TB Infection
In a head-to-head clinical study, Qiagen’s QFT test confirms lower prevalence of TB infection in China, and supports screening and preventive treatment for vulnerable populations.
Read More
Critical Path Institute Receives Grant 
to Accelerate Tuberculosis Diagnostics
A multiyear grant from the Bill & Melinda Gates Foundation will fund an innovative global data platform
 designed to streamline tuberculosis diagnosis and treatment.
Read More